Author:
Brito Marcelo,Rufatto Rosilene,Murta Felipe,Sampaio Vanderson,Balieiro Patrícia,Baía-Silva Djane,Castro Vanessa,Alves Brenda,Alencar Aline,Duparc Stephan,Grewal Daumerie Penny,Borghini-Fuhrer Isabelle,Jambert Elodie,Peterka Cássio,Edilson Lima Francisco,Carvalho Maia Leonardo,Lucena Cruz Catherine,Maciele Bruna,Vasconcelos Mariana,Machado Myrna,Augusto Figueira Elder,Alcirley Balieiro Antônio,Menezes Alexandre,Ataídes Roberta,Batista Pereira Dhelio,Lacerda Marcus
Funder
Newcrest Mining Limited
Her Majesty's Government of the United Kingdom of Great Britain and Northern Ireland
Conselho Nacional de Desenvolvimento Científico e Tecnológico
Bill and Melinda Gates Foundation
Medicines for Malaria Venture
Fundação de Amparo à Pesquisa do Estado do Amazonas
Ministry of Health
GlaxoSmithKline
FIOCRUZ
Reference26 articles.
1. World malaria report,2022
2. Evaluation of the malaria elimination policy in Brazil: a systematic review and epidemiological analysis study;Melo;Trop Biomed,2020
3. Prevalence of glucose 6-phosphate dehydrogenase deficiency in highly malaria-endemic municipalities in the Brazilian Amazon: a region-wide screening study;Nascimento;Lancet Reg Health Am,2022
4. Haemolysis in G6PD heterozygous females treated with primaquine for Plasmodium vivax malaria: a nested cohort in a trial of radical curative regimens;Chu;PLoS Med,2017
5. Primaquine-induced haemolysis in females heterozygous for G6PD deficiency;Chu;Malar J,2018